7-117548628-GTTTTTT-GTTTTT
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_000492.4(CFTR):c.1210-6delT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000492.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFTR | NM_000492.4 | c.1210-6delT | splice_region_variant, intron_variant | Intron 9 of 26 | ENST00000003084.11 | NP_000483.3 | ||
CFTR-AS1 | NR_149084.1 | n.222-6090delA | intron_variant | Intron 2 of 2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000709 AC: 10AN: 1411052Hom.: 0 Cov.: 36 AF XY: 0.00000712 AC XY: 5AN XY: 702200
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not provided Uncertain:2
- -
Also known as c.1210-6delT, IVS8 6T, IVS8 T6, 1342-12 to 1342-6 delT, 1342-6delT; referred to as the 6T allele; Observed with another variant for which phase was unknown, in patients with congenital absence of vas deferens in the published literature (PMID: 15070876, 15562283); Observed in the heterozygous state in individuals with bronchiectasis and chronic pancreatitis (PMID: 12952861, 25492507); This variant is associated with the following publications: (PMID: 17539902, 18350634, 16212675, 15121783, 15070876, 23554779, 12952861, 30811104, 22191729, 15562283, 23092102, 30450785, 25492507, 20879059, 32757986) -
not specified Uncertain:1
Variant summary: CFTR c.1210-12[6] (also known as 6T allele or c.1210-6delT) involves the deletion of an intronic thymine nucleotide from a poly-T tract that is adjacent to a polymorphic TG repeat motif. 4/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 4.8e-05 in 247720 control chromosomes (gnomAD and publications). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. The variant has been reported in non-CF individuals in the literature including individuals affected with bronchial asthma, chronic bronchitis, bronchiectasis, CBAVD and chronic pancreatitis (e.g. Dayangac_2004, Lee_2003, Nakano_2015, Rohlfs_2003, Viel_2005, Wang_2012) but also, in East Asian controls (e.g. Fujiki_2004, Chang_2007, Huang_2008, Jin_2012, Iso_2019). These reports do not provide unequivocal conclusions about association of the variant with Cystic Fibrosis. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance until additional evidence of clinical and functional importance becomes available. -
Cystic fibrosis Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at